Scholars Research Library

Scholars Research Library

A-Z Journals


Peter Smith

Editorial office, Annals of Experimental Biology, Uxbridge, United Kingdom


  • Commentry   
    Analyzing bempedoic acid's effectiveness in treating hyperlipidemia clinically
    Author(s): Peter Smith*

    An innovative, first-in-class oral lipid-lowering medication is Bempedoic acid (BA). Since the end of 2020, BA has been commercialized throughout Europe as an add-on therapy for patients with high/very high cardiovascular risk who are not reaching LDL-C goals with existing lipid-lowering medications. BA has received approval from both the European Medicines Agency and the Food and Drug Administration. Italian lipid management experts recently met to discuss several unresolved issues regarding the therapeutic relevance of BA features and BA-related practical clinical issues. The panel agreed to have its thoughts collected in a ten-question format. .. Read More»
    DOI: 0

    Abstract HTML PDF

Recommended Conferences
Google Scholar citation report
Citations : 236

Annals of Experimental Biology received 236 citations as per Google Scholar report

Indexed In